Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
UBS
Moodys
Merck
Farmers Insurance
Covington
US Department of Justice
AstraZeneca
Federal Trade Commission
Johnson and Johnson

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075101

« Back to Dashboard
NDA 075101 describes ACYCLOVIR, which is a drug marketed by Watson Labs, Amneal Pharms, Actavis Elizabeth, Apotex Inc, Glenmark Pharms Ltd, Mylan Pharms Inc, Zydus Pharms Usa Inc, Teva Pharms, Abbvie, Hi Tech Pharma, Mylan, Teva, Dava Pharms Inc, Fougera Pharms Inc, Chartwell Molecules, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Tolmar, Actavis Mid Atlantic, Cadila Pharms Ltd, Lek Pharm, Carlsbad Technology, Taro, Roxane, Ranbaxy, Sun Pharm Inds Ltd, Carlsbad, Heritage Pharms Inc, Boscogen, Eurohlth Intl Sarl, Aurobindo Pharma Ltd, Fresenius Kabi Usa, Hospira, Mylan Labs Ltd, Teva Parenteral, Hikma Pharms, Athenex Inc, and Apothecon, and is included in sixty NDAs. It is available from sixty-two suppliers. Additional details are available on the ACYCLOVIR profile page.

The generic ingredient in ACYCLOVIR is acyclovir sodium. There are fifty-five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the acyclovir sodium profile page.

Summary for NDA: 075101

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength200MG
Approval Date:Apr 15, 1998TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Fuji
Covington
Accenture
Express Scripts
Healthtrust
Farmers Insurance
UBS
Fish and Richardson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot